본문 바로가기

Multiple drug-coated balloons can be used effectively for peripheral arterial disease including long femoropopliteal lesions

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q2KCI Q1
저널
Annals of Surgical Treatment and Research101(2) · pp.120 · 2021
피인용
Web of Science 1Scopus 0KCI 0
FWCI (Scopus)
0
JCR IF
JCR 2020 1.859
ISSN
2288-6575

저자

  1. 추원공제1저자Pusan Natl Univ, Div Vasc & Endovasc Surg, Dept Surg, Yangsan Hosp, Yangsan, South Korea
  2. 김동현Pusan Natl Univ, Div Vasc & Endovasc Surg, Dept Surg, Yangsan Hosp, Yangsan, South Korea
  3. 권수경Pusan Natl Univ, Div Vasc & Endovasc Surg, Dept Surg, Yangsan Hosp, Yangsan, South Korea
  4. 박제형Pusan Natl Univ, Div Vasc & Endovasc Surg, Dept Surg, Yangsan Hosp, Yangsan, South Korea
  5. 정혁재Pusan Natl Univ Hosp, Div Vasc & Endovasc Surg, Dept Surg, Busan, South Korea
  6. 이상수교신저자Pusan Natl Univ, Div Vasc & Endovasc Surg, Dept Surg, Yangsan Hosp, Yangsan, South Korea

초록

Copyright © 2021, the Korean Surgical SocietyPurpose: Drug-coated balloons have shown successful results in treating peripheral arterial occlusive disease. However, using multiple balloons for long femoropopliteal lesions (>15 cm) remains challenging; their safety and efficacy need to be explored. Therefore, we aimed to evaluate the outcomes of multiple drug-coated balloons for long femoropopliteal lesions in terms of the primary patency, freedom from clinically-driven target lesion revascularization, and mortality. Methods: Between April 2015 and September 2018, 96 patients (117 limbs) who underwent balloon angioplasty using at least 2 drug-coated balloons for femoropopliteal lesions were retrospectively reviewed. Lesions were classified as TransAtlantic Inter-Society Consensus (TASC) classification C or D. The outcomes were analyzed using Kaplan-Meyer analysis. Results: The mean age of 96 enrolled patients was 70.8 ± 9.8 years, and 83 patients were males (86.5%). Critical limb-threatening ischemia was found in 29 cases (24.8%). The mean lesion and drug-coated balloon lengths per limb were 292.3 ± 77.8 mm and 325.0 ± 70.2 mm, respectively. The technical success rate was 99.2%. A total of 82.1% were followed-up for more than 6 months. The primary patency rates at 12 and 24 months were 71.4% and 41.7%, respectively; freedom from clinically-driven target lesion revascularization rates were 96.4% and 71.0% at 12 and 24 months, respectively. The Kaplan-Meier estimate of the 2-year overall cumulative mortality rate was 20.8%. All identified mortalities appeared to be less associated with paclitaxel. Conclusion: Drug-coated balloons can be effectively used without drug-related mortality, even for long lesions, such as TASC classification C or D femoropopliteal lesions.

키워드

AngioplastyArterial occlusive diseasesFemoral arteryMortalityPaclitaxelANGIOPLASTYINTERVENTIONSMANAGEMENTSTENTS

식별자

Scopus EID
2-s2.0-85112012445
WoS UID
000684061100007
KCI
ART002741255